摘要
1980年至1990年间,我院对56例有病理证实的乳腺癌术后胸壁复发患者进行了放疗,放疗后病灶完全消失30例,残存20例,6例无变化或恶化。1、3、5年生存率分别为87.5%、58、9%、26.8%。手术组与术后放疗组5年生存率无明显差异(29.0%与24.0%),作者统计,术后腋淋巴结转移数目与胸壁复发有直接关系,乳腺癌术后腋淋巴结阳性数目递增,胸壁复发率随之增高。而乳癌术后放疗有可能延迟复发时间,故绝经前妇女、雌激素受体阳性及腋下淋巴结阳性患者,不仅要进行内分泌治疗而且要进行胸壁和区域淋巴引流区放疗,对术后胸壁复发患者,应积极行放射治疗,复发灶放疗剂量以50Gy~70Gy为宜。
The role of radiotherapy in the breast cancer patients with chestwall recurrence was evaluated. Form 1980 to 1990, 56 cases of breast cancer with chestwall recurrence were treated by radiotherapy in this hospital. 30 cases were CR, 20 were PR,another 6 patients failed to the treatment. The 1, 3, 5-year survial rate were 87.5%, 58.9%, 26.8% respectively. The 5year survial rate is of no difference between the operation group and postoperational radiotherepy group (29.0% to 24.0%). The positive number of axillary lymphnode was ralated with the recurrence of chestwall. The greater the positive number of axillary lymph node, the higher the recurrence on chestwall. The auther believes that patients of prior menopause and with positive ER and positive axillary lymph node,ought to receive not only endocrine treatment,but also radiotherapy to the chestwall And regional lymph field' For patients of chestwall recurrence the dose of DT 50 Gy~70 Gy radiotherapy is suitable.
出处
《河南肿瘤学杂志》
1996年第3期185-187,共3页
Henan Journal of Oncology
关键词
乳腺癌
胸壁复发
放射疗法
breast cancer, chestwall recurrence, radiotherapy